Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03014882 |
Date of registration:
|
06/01/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Sperm DNA Damage in ß-thalassemia Major: Is There a Role for Antioxidants?
|
Scientific title:
|
Sperm DNA Damage in ß-thalassemia Major: Is There a Role for Antioxidants? |
Date of first enrolment:
|
February 2015 |
Target sample size:
|
30 |
Recruitment status: |
Active, not recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03014882 |
Study type:
|
Interventional |
Study design:
|
Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
Phase 1/Phase 2
|
|
Countries of recruitment
|
Egypt
| | | | | | | |
Contacts
|
Name:
|
Heba H Elsedfy, Professor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Ain Shams University |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Pubertal patients with beta thalassemia major
Exclusion Criteria:
- Associated endcrinopathy
Age minimum:
16 Years
Age maximum:
N/A
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Fertility Decreased Male
|
Endocrine Disease
|
DNA Damage
|
Intervention(s)
|
Drug: L-Carnitine and N-acetyl cysteine
|
Primary Outcome(s)
|
DNA fragmentation index
[Time Frame: 6 months]
|
Secondary ID(s)
|
Endocrinology PECASU
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|